Skip to content

Based on clinical big data, a built-in closed-loop control system for precise regulation of blood glucose after pancreatic surgery was established—Based on clinical big data, the changes of blood glucose after pancreatic surgery were retrospectively analyzed

Establishing a built-in closed-loop control system for precise blood glucose regulation after pancreatic surgery based on clinical big data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092044
Enrollment
Unknown
Registered
2024-11-07
Start date
2023-08-21
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic related diseases

Interventions

control group:The control group consisted of nurses who consulted the liquid sugar content table according to the doctor's instructions, and calculated the sugar content of different parenteral nutrit
intervention group:On the basis of the control group, the intervention group implemented a built-in closed-loop control system for precise regulation of postoperative blood glucose after pancreatic su

Sponsors

Peking Union Medical College Hospital of the Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Age 18-75 years old; 2. Patients diagnosed with pancreatic or duodenal tumors, bile duct or ampullary malignant tumors, and other tumor diseases in histopathology who require pancreatic surgery (including pancreaticoduodenectomy, pancreaticostomy, and segmental pancreatectomy); 3. Enhanced CT diagnosis can be or may be resected without distant metastasis; 4. Informed consent.

Exclusion criteria

Exclusion criteria: 1.Simultaneously receiving other treatment studies 2. Patients with severe complications such as bleeding within 72 hours after surgery; 3. Suffering from serious respiratory diseases or chronic diseases such as uncontrollable diabetes and hypertension; 4. Suffering from heart disease with obvious clinical symptoms; 5. Suffering from mental disorders.

Design outcomes

Primary

MeasureTime frame
hourly insulin dose;

Secondary

MeasureTime frame
Blood glucose control level;system stability;postoperative complication rate; hospitalization time and expenses;

Countries

China

Contacts

Public ContactWeinan Liu

Peking Union Medical College Hospital of the Chinese Academy of Medical Sciences

liuwn0122@126.com+86 69152606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026